Canlyniadau Chwilio - Megan I. Samuelson

  • Dangos 1 - 4 canlyniadau o 4
Mireinio'r Canlyniadau
  1. 1
    Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing

    Successful Patient-Derived Organoid Culture of Gynecologic Cancers for Disease Modeling and Drug Sensitivity Testing gan Jianling Bi, A.M. Newtson, Yuping Zhang, Eric J. Devor, Megan I. Samuelson, Kristina W. Thiel, Kimberly K. Leslie

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Preferential recognition of a microbial metabolite by human V 2V 2 T cells

    Preferential recognition of a microbial metabolite by human V 2V 2 T cells gan Kia Joo Puan, Jin Chen, H. Wang, Ghanashyam Sarikonda, Amy M. Raker, H. K. Lee, Megan I. Samuelson, E. Märker‐Hermann, Ljiljana Paša‐Tolić, E. Nieves, José‐Luis Giner, Tomohisa Kuzuyama, Craig T. Morita

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study

    A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study gan David Bender, Michael W. Sill, Heather A. Lankes, Henry Reyes Pineda, Christopher J. Darus, James E. Delmore, Jacob Rotmensch, Heidi J. Gray, Robert S. Mannel, Jeanne M. Schilder, Mark Hunter, Carolyn K. McCourt, Megan I. Samuelson, Kimberly K. Leslie

    Cyhoeddwyd 2015
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    <i>TP53</i> Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study

    <i>TP53</i> Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology... gan Kristina W. Thiel, Eric J. Devor, Virginia L. Filiaci, David G. Mutch, Katherine Moxley, Angeles Alvarez Secord, Krishnansu S. Tewari, Megan McDonald, Cara Mathews, Casey Cosgrove, Summer Dewdney, Carol Aghajanian, Megan I. Samuelson, Heather A. Lankes, Robert A. Soslow, Kimberly K. Leslie

    Cyhoeddwyd 2022
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: